These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 708990)

  • 1. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR; Kelly PH
    Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--1. Rubidium.
    Wang H; Grahame-Smith DG
    Neuropharmacology; 1992 May; 31(5):413-9. PubMed ID: 1382243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG
    Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--2. Caesium.
    Wang H; Grahame-Smith DG
    Neuropharmacology; 1992 May; 31(5):421-4. PubMed ID: 1528394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1980 May; 69(1):69-80. PubMed ID: 6769527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological studies on the interactions between tryptamine and 5-hydroxytryptamine.
    Jones RS
    Br J Pharmacol; 1981 Jun; 73(2):485-93. PubMed ID: 6972243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic involvement in pharmacological action of the anxiolytic-sedatives thalidomide and supidimide.
    Youdim MB; Ashkenazi R
    Eur J Pharmacol; 1985 Dec; 119(1-2):39-46. PubMed ID: 2867921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.